NASDAQ:PFSA

Profusa stock whipsaws: PFSA dips premarket after 78% surge on debt restructuring

Profusa Inc shares were down about 12% at 10.7 cents in premarket trading on Wednesday, after soaring 78% to 12.2 cents in the prior session as investors reacted to the company’s debt restructuring. Tuesday’s session saw the stock trade between 10.8 cents and 17 cents, with volume jumping to about 822 million shares. StockAnalysis

31 December 2025

NASDAQ:PFSA·Stock Market

Profusa (PFSA) Stock Skyrockets 36% on Milestone News – Can This Biotech Sensor Play Rebound?

Profusa’s after-hours surge came on the heels of a positive company update. The California-based digital health firm announced it has completed key manufacturing initiatives, creating enough production capacity to supply more than twice the units needed to meet its 2026 revenue goals for the Lumee™ continuous oxygen sensor systembenzinga.com. Fred Knechtel, Profusa’s CFO, said the team is “laser-focused on achieving revenue from sales of Lumee tissue oxygen monitoring systems… at the start of the second quarter of 2026,” with inventory shipments to distributors planned in Q1 2026benzinga.com. To support that timeline, Profusa finished the first full run of sensor production in October and even began production of its Lumee injector “pens,” according to the updatebenzinga.com.

29 October 2025